NDC 42543-719 – Emtricitabine and Tenofovir Disoproxil Fumarate

Emtricitabine 200 mg/1; Tenofovir Disoproxil Fumarate 300 mg/1 · Tablet · Oral

Human Prescription Drug

Product NDC42543-719

Product details

Brand name
Emtricitabine and Tenofovir Disoproxil Fumarate
Generic name
EMTRICITABINE and TENOFOVIR Disoproxil Fumarate
Labeler
Strides Pharma Inc.
Dosage form
Tablet
Route
Oral
Marketing category
ANDA · ANDA091055
Marketed since
March 30, 2021
Listing expires
December 31, 2026
Pharmacologic class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Emtricitabine and tenofovir disoproxil fumarate →

Package NDC codes (1)

Package NDCDescriptionSince
42543-719-0430 TABLET in 1 BOTTLE, PLASTIC (42543-719-04)Mar 30, 2021

Other Emtricitabine and tenofovir disoproxil fumarate products